Phue Khaing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Phue Khaing has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adrienne N. Poon
Department of Medicine, School of Medicine & Health Sciences, George Washington University, Washington DC, USA
2 shared publications C. Walker
Medicine, George Washington University, Washington, DC, United States
2 shared publicationsJ.E. Dobbs
Medicine, George Washington University, Washington, DC, United States
2 shared publicationsA.Y. Chang
Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States
1 shared publicationArpana Paruchuri
Department of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University Hospital, Philadelphia, PA, USA
1 shared publicationBharat K Awsare
Division of Pulmonary and Critical Care Medicine, Jane and Leonard Korman Respiratory Institute, Department of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University Hospital, Philadelphia, PA, USA
1 shared publication
Latest Publications
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6801
Pulmonary Function Testing in Post-Acute Sequelae From COVID-19
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A6801
Pulmonary Function Testing in Post-Acute Sequelae From COVID-19
- 1 January 2020
- Published by Taylor & Francis in Hospital Practice
- Vol. 48 (1) , 23-28
First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation
Objectives: The Pulmonary Embolism Response Team (PERT) model is now widely adopted in many institutions to provide multidisciplinary care for patients with acute pulmonary embolism (PE). However, descriptive experiences of PERT operations and studies on clinical outcomes remain limited. Methods: We performed a retrospective review of PERT activations at an academic tertiary care center, with secondary aims to study outcomes associated with performing catheter directed therapies (CDT). Results: The intermediate high-risk PE category was most frequent (n= 40, 76.9%) among the 52 total cases evaluated during the study period. There was one in-hospital mortality, associated with hospice admission for a non-PE diagnosis. Six patients (11.5%) experienced a bleeding complication of any severity. Anticoagulation (AC) alone was recommended in 30 patients (57.7%) and CDT was performed in 16 patients (30.8%). There were no significant differences in patient characteristics or disease severity between patients in the AC group versus the CDT group, except for a higher prevalence of malignancy in the AC group (p = 0.037). Patients who underwent CDT demonstrated a lower, albeit non-significant, median intensive care unit (ICU) length of stay (LOS) (3 vs. 4 days, p = 0.34) and hospital LOS (4 vs. 5 days, p = 0.25), as compared to patients receiving AC alone. Bleeding rates were similar between the two groups (6.7% vs. 6.3%, p = 1.0). Conclusions: Adoption of the PERT model at an academic tertiary care center was associated with acceptably low rates of mortality and bleeding, similar to other published studies. Performing CDT in select patients under PERT consultation may be associated with shorter ICU and hospital LOS; however, larger studies are needed to validate this finding.
- 1 January 2020
- Published by Taylor & Francis in Hospital Practice
- Vol. 48 (1) , 23-28
First year experience of a pulmonary embolism response team with comparisons of outcomes between catheter directed therapy versus standard anticoagulation
Objectives: The Pulmonary Embolism Response Team (PERT) model is now widely adopted in many institutions to provide multidisciplinary care for patients with acute pulmonary embolism (PE). However, descriptive experiences of PERT operations and studies on clinical outcomes remain limited. Methods: We performed a retrospective review of PERT activations at an academic tertiary care center, with secondary aims to study outcomes associated with performing catheter directed therapies (CDT). Results: The intermediate high-risk PE category was most frequent (n= 40, 76.9%) among the 52 total cases evaluated during the study period. There was one in-hospital mortality, associated with hospice admission for a non-PE diagnosis. Six patients (11.5%) experienced a bleeding complication of any severity. Anticoagulation (AC) alone was recommended in 30 patients (57.7%) and CDT was performed in 16 patients (30.8%). There were no significant differences in patient characteristics or disease severity between patients in the AC group versus the CDT group, except for a higher prevalence of malignancy in the AC group (p = 0.037). Patients who underwent CDT demonstrated a lower, albeit non-significant, median intensive care unit (ICU) length of stay (LOS) (3 vs. 4 days, p = 0.34) and hospital LOS (4 vs. 5 days, p = 0.25), as compared to patients receiving AC alone. Bleeding rates were similar between the two groups (6.7% vs. 6.3%, p = 1.0). Conclusions: Adoption of the PERT model at an academic tertiary care center was associated with acceptably low rates of mortality and bleeding, similar to other published studies. Performing CDT in select patients under PERT consultation may be associated with shorter ICU and hospital LOS; however, larger studies are needed to validate this finding.